The more weight they lost, the better their joints felt
SOUL Published in the New England Journal of Medicine , SOUL was a double-blind, placebo-controlled, event-driven superiority trial, enrolling 9650 participants who were randomised to receive oral semaglutide (up to 14 mg once daily) or placebo, alongside standard care for diabetes and CVD (McGuire et al, 2025)
The Role of Peptide Therapy in Weight and Hormonal Health Tirzepatide sits within a broader category of treatments that use peptide molecules to target specific receptors in the body
This conversion is generally unnecessary for patients using FDA-approved pre-filled pens, as these devices are pre-calibrated to deliver doses in milligrams
Sarah Long, DNP Clinical Lead Biltmore Park Suite 218, Asheville Neuromodulators Dysport & Xeomin Prescription neuromodulators that temporarily relax the muscles responsible for expression lines forehead, frown lines, crow's feet, and more